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OBJECTIVE: The main analysis in this study assessed the effectiveness of 
using acupuncture as an adjunct therapy to Selective Serotonin Reuptake 
Inhibiting (SSRI’s) antidepressants in the treatment of Major Depressive 
Disorder (MDD). A secondary analysis explored if the intervention led to any 
differences between subjects based on sex. 
 
DESIGN: This study used a randomised, single blind, repeated measures 
design. A standardised acupuncture intervention was administered as an 
adjunct therapy to SSRI. The researchers proposed a best-fit synthesis model 
which upheld the integrity of the scientific method whilst maintaining the integrity 
of the Chinese Medicine (CM) model. Inclusion in the study required subjects to 
both satisfy the criteria for MDD and to present with liver qi stagnation (a CM 
diagnostic category). The Beck Depression Inventory and the Hamilton Rating 
Scale for Depressive Illness were the primary measures of depression.  
 
RESULTS: The outcomes of the study showed that those who received the 
acupuncture intervention experienced a statistically significant improvement in 
their depression scores compared to those who participated in a wait list control 
group who experienced no change. Analysis based on diagnostic status (DSM-
IV-TR) indicated an 87.3% remission rate. An eight week follow up analysis 
indicated subjects were able to maintain their improvement and remain 
significantly less depressed than they were before receiving the intervention. 
The data were stratified according to sex and suggested there were few 
differences between females and males. Further analysis was conducted to 
include an anxiety scale (STAI) and a general mental health scale (SCL-90). As 
with the depression analysis, the subjects showed statistically significant 
improvement in anxiety and mental health dimension scores. This was similarly 




CONCLUSION: Acupuncture may be an effective adjunct therapy to SSRIs for 
both females and males in treatment of MDD. In addition to this, the outcomes 
from this study have interesting implications within the wider context of the CM 
model. It would appear that in addition to the link between liver qi stagnation and 
depression, there is also a link to a broader spectrum of mental health 
dimensions. 
 
